Business Standard

Tuesday, December 24, 2024 | 06:27 PM ISTEN Hindi

Notification Icon
userprofile IconSearch

World Coronavirus Dispatch: Rare nerve complication with J&J vaccine

FDA adds warning on Johnson & Johnson vaccine, lockdown extensions looms in Sydney and other pandemic-related news across the globe

Africa, Coronavirus, Covid-19
Premium

BS Reporter New Delhi
FDA warns of potential rare nerve complication with Johnson & Johnson coronavirus vaccine

The US Food and Drug Administration updated the label on Johnson & Johnson's coronavirus vaccine Monday to warn of the possible increased risk of a rare neurological complication called Guillain-Barré syndrome. While the FDA said it had not established the vaccine could cause the syndrome, it noted an increase in reports of the sometimes paralyzing condition. Read more

Let's look at the global statistics

Global infections: 187,355,083

Global deaths: 4,041,027

Vaccine doses administered: 3,479,804,410

Nations with most cases: US (33,890,833), India (30,874,376), Brazil (19,106,971),

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in